Topic Name
Introduction
Epidemiology & Risk Factors
Clinical Presentation
Diagnosis
Management
Prevention & Follow-up
Neonatal Urinary Tract Infection
Key Points
UTIs affect 1-2% of all newborns and up to 10% of febrile neonates
More common in uncircumcised male neonates in first 3 months
Can lead to renal scarring if not properly treated
Requires prompt recognition and appropriate antimicrobial therapy
Introduction
Neonatal urinary tract infection represents a significant cause of morbidity in the first month of life. Early recognition and appropriate management are crucial to prevent long-term renal complications. The condition presents unique diagnostic and therapeutic challenges due to non-specific clinical presentations and the technical difficulties in obtaining reliable urine samples.
Epidemiology
Incidence: 1-2% of all newborns
Gender distribution:
Males > Females in first 3 months
Females > Males after 3 months
Peak occurrence: 2-6 weeks of life
Risk Factors
Anatomical Factors
Urinary tract anomalies
Vesicoureteral reflux
Posterior urethral valves
Host Factors
Prematurity
Male uncircumcised status
Immunocompromised state
External Factors
Catheterization
Poor perineal hygiene
Previous UTIs
Clinical Presentation
Common Presentations
Non-specific Signs
Fever or hypothermia
Poor feeding
Lethargy
Irritability
Growth failure
Specific Signs
Jaundice (especially prolonged)
Vomiting
Diarrhea
Abdominal distention
Malodorous urine
Associated Conditions
Sepsis
Meningitis
Bacteremia
Diagnostic Approach
Urine Collection Methods
Suprapubic Aspiration (Gold Standard)
Most reliable method
Any growth is significant
Catheterization
Alternative when SPA not feasible
≥ 50,000 CFU/mL significant
Clean Catch (Less Reliable in Neonates)
Laboratory Evaluation
Urinalysis
Leukocyte esterase
Nitrites
Microscopy for WBCs
Gram stain
Urine Culture (Essential)
Additional Tests
Complete blood count
C-reactive protein
Blood culture
CSF analysis if indicated
Therapeutic Approach
Initial Management
Empiric Antibiotics
Ampicillin + Gentamicin or
Third-generation cephalosporin
Duration: 10-14 days for uncomplicated UTI
14-21 days for complicated cases
Monitoring Response
Clinical improvement within 48-72 hours
Repeat urine culture if poor response
Monitor renal function
Imaging Studies
Initial Evaluation
Renal and bladder ultrasound (within 48 hours)
VCUG consideration after infection resolves
Advanced Imaging
DMSA scan if indicated
MR urogram for complex cases
Prevention and Follow-up
Preventive Measures
Proper hygiene practices
Adequate hydration
Prompt diaper changes
Regular voiding patterns
Follow-up Care
Regular monitoring of growth
Blood pressure surveillance
Renal function assessment
Antibiotic prophylaxis if indicated
Long-term Considerations
Monitor for recurrence
Assessment for renal scarring
Growth and development monitoring
Family education and counseling
Further Reading
Refresh Page
